HK1108835A1 - Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases - Google Patents
Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseasesInfo
- Publication number
- HK1108835A1 HK1108835A1 HK07114030.6A HK07114030A HK1108835A1 HK 1108835 A1 HK1108835 A1 HK 1108835A1 HK 07114030 A HK07114030 A HK 07114030A HK 1108835 A1 HK1108835 A1 HK 1108835A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- octenidine
- used against
- oral
- pharyngeal
- against inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a lozenge, especially based on caramel, which is suitable for the topical treatment of inflammatory oral and pharyngeal diseases. Said lozenge contains octenidine, preferably in the form of octenidine dihydrochloride, as an active substance such that a therapeutically effective amount of octenidine, preferably octenidine dihydrochloride, is released during sucking when the lozenge is administered and sucked in a patient's oral and pharyngeal cavity.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004049798 | 2004-10-12 | ||
DE102004052308A DE102004052308B4 (en) | 2004-10-12 | 2004-10-28 | Octenidine-containing lozenges against inflammatory diseases of the mouth and throat |
PCT/EP2005/008973 WO2006039961A1 (en) | 2004-10-12 | 2005-08-19 | Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1108835A1 true HK1108835A1 (en) | 2008-05-23 |
Family
ID=35149087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07114030.6A HK1108835A1 (en) | 2004-10-12 | 2007-12-21 | Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1799186B1 (en) |
CN (1) | CN101052373B (en) |
AT (1) | ATE398441T1 (en) |
DE (2) | DE102004052308B4 (en) |
EA (1) | EA011991B1 (en) |
ES (1) | ES2309790T3 (en) |
GE (1) | GEP20094809B (en) |
HK (1) | HK1108835A1 (en) |
HR (1) | HRP20080438T3 (en) |
NO (1) | NO20071795L (en) |
PL (1) | PL1799186T3 (en) |
RS (1) | RS50593B (en) |
SI (1) | SI1799186T1 (en) |
UA (1) | UA83320C2 (en) |
WO (1) | WO2006039961A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101842085B (en) | 2007-10-31 | 2013-01-30 | 麦克内尔-Ppc股份有限公司 | Orally disintegrated dosage form |
RU2497679C2 (en) | 2008-10-02 | 2013-11-10 | Милан Инк. | Method of making multilayer adhesive laminated material |
EP2201951A1 (en) * | 2008-11-14 | 2010-06-30 | Ahmet Melih Aydinoglu | Octenidine composition |
US9610224B2 (en) | 2009-09-24 | 2017-04-04 | Johnson & Johnson Consumer Inc. | Manufacture of tablet in a die utilizing powder blend containing water-containing material |
US20110318411A1 (en) | 2010-06-24 | 2011-12-29 | Luber Joseph R | Multi-layered orally disintegrating tablet and the manufacture thereof |
PL2701681T3 (en) | 2011-04-29 | 2017-03-31 | Moberg Pharma Ab | Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat |
DE102012000976A1 (en) * | 2012-01-20 | 2013-07-25 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Composition for topical treatment |
DE102012007212A1 (en) * | 2012-04-11 | 2013-10-17 | Merz Pharma Gmbh & Co. Kgaa | Preparation for topical application to mucous membranes with polyhexanide as active ingredient |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
DE202013000446U1 (en) * | 2012-10-04 | 2013-10-07 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Composition, in particular pharmaceutical composition, in particular for administration in hoarseness and sore throat |
MX368159B (en) | 2014-01-10 | 2019-09-20 | Johnson & Johnson Consumer Inc | Process for making tablet using radiofrequency and lossy coated particles. |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ210386A (en) * | 1983-12-09 | 1987-11-27 | Sterling Drug Inc | Saccharine salts and dentrifice compositions |
AU7204787A (en) * | 1986-03-17 | 1987-10-09 | Oral Research Laboratories, Inc. | Treatment of dental surfaces with plaque retardants |
GB9204410D0 (en) * | 1992-02-29 | 1992-04-15 | Smithkline Beecham Plc | Method of treatment |
US6350438B1 (en) * | 1998-02-27 | 2002-02-26 | The Procter & Gamble Company | Oral care compositions comprising chlorite and methods |
DE10026716A1 (en) * | 2000-05-30 | 2001-12-13 | Ferton Holding Sa | Prophylactic mouthwash solution, especially for use together with an abrasive powder, comprises an antimicrobial or bacteriostatic and tooth-remineralizing agent |
PT1294383E (en) * | 2000-06-30 | 2008-10-08 | Procter & Gamble | Oral compositions comprising antimicrobial agents for the prevention of systemic diseases |
DE10205883A1 (en) * | 2002-02-13 | 2003-08-21 | Schuelke & Mayr Gmbh | Aqueous antiseptic based on bispyridiniumalkanes |
-
2004
- 2004-10-28 DE DE102004052308A patent/DE102004052308B4/en active Active
-
2005
- 2005-08-19 ES ES05777078T patent/ES2309790T3/en active Active
- 2005-08-19 GE GEAP200510057A patent/GEP20094809B/en unknown
- 2005-08-19 EP EP05777078A patent/EP1799186B1/en active Active
- 2005-08-19 WO PCT/EP2005/008973 patent/WO2006039961A1/en active Application Filing
- 2005-08-19 CN CN2005800369212A patent/CN101052373B/en not_active Expired - Fee Related
- 2005-08-19 AT AT05777078T patent/ATE398441T1/en active
- 2005-08-19 RS RSP-2008/0346A patent/RS50593B/en unknown
- 2005-08-19 PL PL05777078T patent/PL1799186T3/en unknown
- 2005-08-19 UA UAA200705041A patent/UA83320C2/en unknown
- 2005-08-19 DE DE502005004475T patent/DE502005004475D1/en active Active
- 2005-08-19 EA EA200700777A patent/EA011991B1/en not_active IP Right Cessation
- 2005-08-19 SI SI200530355T patent/SI1799186T1/en unknown
-
2007
- 2007-04-03 NO NO20071795A patent/NO20071795L/en not_active Application Discontinuation
- 2007-12-21 HK HK07114030.6A patent/HK1108835A1/en not_active IP Right Cessation
-
2008
- 2008-09-08 HR HR20080438T patent/HRP20080438T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101052373A (en) | 2007-10-10 |
RS50593B (en) | 2010-05-07 |
EA200700777A1 (en) | 2007-10-26 |
HRP20080438T3 (en) | 2008-10-31 |
DE102004052308B4 (en) | 2013-04-04 |
ES2309790T3 (en) | 2008-12-16 |
NO20071795L (en) | 2007-07-06 |
UA83320C2 (en) | 2008-06-25 |
ATE398441T1 (en) | 2008-07-15 |
EP1799186B1 (en) | 2008-06-18 |
DE102004052308A1 (en) | 2006-04-13 |
GEP20094809B (en) | 2009-10-26 |
EA011991B1 (en) | 2009-06-30 |
DE502005004475D1 (en) | 2008-07-31 |
WO2006039961A1 (en) | 2006-04-20 |
SI1799186T1 (en) | 2008-10-31 |
CN101052373B (en) | 2010-06-16 |
EP1799186A1 (en) | 2007-06-27 |
PL1799186T3 (en) | 2008-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1108835A1 (en) | Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases | |
WO2002069945A3 (en) | Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors | |
YU71901A (en) | NOVEL MEDICAMENT COMPOSITIONS, BASED ON ANTICHOLINERGICALLY EFFECTIVE COMPOUNDS AND beta-MIMETICS | |
SG169233A1 (en) | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation | |
RS20090105A (en) | Medicament compositions based on tiotropium salts and on salmetrol salts | |
DE60126923D1 (en) | THERAPEUTIC COMPOSITIONS COMPRISING ANTI-HYPOTENSIVA AND ANTIANGIOGENICA | |
ZA200408649B (en) | Opthamological use of roflumilast for the treatment of diseases of the eye | |
NO20031019L (en) | Sustained oxymorphone release formulations | |
IL172705A (en) | Use of 4-(2-chloroethyl)-1-((2-cyclohexen-1-yl)hydroxymethyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione and its esters in the manufacture of medicaments | |
HK1102991A1 (en) | Pharmaceutical formulation of decitabine | |
BR0312573A (en) | Phenyl- [4- (3-phenyl-1h-pyrazol-4-yl) -pyrimidin-2-yl] -amine derivatives | |
WO2008022256A3 (en) | Methods and compositions for preventing or treating age-related diseases | |
CY1107465T1 (en) | MELAGATRANI FOR THERAPEUTIC INFECTION | |
SE0102276D0 (en) | Device and method for administering a drug | |
CA2503810A1 (en) | Therapeutic agent for fibromyalgia | |
DE602005021115D1 (en) | METHOD AND COMPOSITIONS FOR ORAL FTS DELIVERY | |
ATE413187T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING INTERFERON TAU | |
WO2006079910A3 (en) | 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity | |
SE0004101D0 (en) | New use | |
SE9902597D0 (en) | New use | |
WO2001074396A8 (en) | Composition and method for promoting oral health | |
WO2004105759A3 (en) | Novel long-acting medicament combinations comprising an anticholinergic agent and a $g(b)2-adrenoreceptor antagonist for the treatment of respiratory tract diseases | |
NZ542305A (en) | Treatment of proliferative diseases with an epothilone derivative and radiation | |
WO2004073627A3 (en) | Novel therapeutic method and compositions for topical administration | |
JO2586B1 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20140819 |